IceCure Medical Announces 1-for-30 Reverse Share Split to Maintain Nasdaq Listing

IceCure Medical announced on Tuesday that it will implement a 1-for-30 reverse share split of its outstanding ordinary shares. The company initiated this action to meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

Under the terms of the split, every 30 issued and outstanding ordinary shares will consolidate into one ordinary share. The company expects the reverse split to take effect following the close of market operations, with trading on a split-adjusted basis beginning shortly thereafter. This adjustment will proportionally reduce the total number of outstanding shares while increasing the price per share by a factor of 30. IceCure Medical stated that the move serves as a strategic measure to maintain its standing on the exchange and comply with Nasdaq’s regulatory listing standards.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI